SOAP Study – Vaccine efficacy study – enrolling MDS patients now11 Apr. 2021
King's College Hospital has secured further funding to monitor more MDS patients, as part of the SOAP study.
This study is going to measure how effective the vaccines are in blood cancer patients and specifically MDS patients, as initial results have shown that the vaccines may not be as effective as in the general population.
The results of this study may then determine next steps for MDS patients, whether a vaccine booster may be needed, or some other way to offer protection from COVID-19.
It is a very important piece of research.
The MDS haematology team is now looking for up to 50 MDS patients to come forward for recruitment, and be followed-up for up to 1 year.
Timing for enrolment is critical – as the first test needs to take place 2 weeks after your second vaccine.
For this study, the tests (swabs) will take place 3 times over the course of 1 year:
> 2 weeks after your 2nd Covid-19 vaccine
> 6 months later
> 1 year later
The study is open to any MDS patients able to travel to King's College Hospital – with the EXCEPTION OF POST-TRANSPLANT PATIENTS.
You DO NOT have to be treated at King's to take part.
MDS UK is helping King's to spread the word, and recruit potential participants.
If interested, please email firstname.lastname@example.org, quoting Reference 'SOAP study-MDS' in the subject header.
Please provide the following information:
- Email address:
- Date of your 2nd Covid-19 vaccine:
- Type of vaccine received (AstraZeneca or Pfizer):
Please also include following statements, as relevant:
- 'I am interested to potentially enrol in the SOAP study for MDS.
- ‘I consent to MDS UK passing on my contact details to the KCH trials team for that purpose.'
Feel free to add any other details that may be relevant.
The King's team will then get in touch to share all further details (via nurses Florence or Johanna).
Due to tight timelines, this SOAP study could not be extended further afield than King's - but it is an excellent number and results will be relevant to the entire country, and even internationally.
So please don't hesitate to express interest already.
King’s really relies on our MDS UK members to come forward for this.